Browsing by Author "Andrade-Campos, Marcio"

Sort by: Order: Results:

  • Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease
    Valero-Tena, Esther; Roca-Espiau, Mercedes; Verdú-Díaz, José; Diaz-Manera, Jordi; Andrade-Campos, Marcio; Giraldo, Pilar (Frontiers, 2023)
    Gaucher disease (GD) is a genetic lysosomal disorder characterized by high bone marrow (BM) involvement and skeletal complications. The pathophysiology of these complications is not fully elucidated. Magnetic resonance ...
  • Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
    Barbui, Tiziano; Andrade-Campos, Marcio; Vannucchi, Alessandro Maria (Nature Research, 2021)
    In a multicenter European retrospective study including 162 patients with COVID-19 occurring in essential thrombocythemia (ET, n = 48), polycythemia vera (PV, n = 42), myelofibrosis (MF, n = 56), and prefibrotic myelofibrosis ...
  • Breakthrough infections in MPN-COVID vaccinated patients
    Barbui, Tiziano; Andrade-Campos, Marcio; Vannucchi, Alessandro Maria (Nature Research, 2022)
  • Cell-Free DNA as a biomarker at diagnosis and follow-up in 256 B and T-Cell lymphomas
    Díez-Feijóo, Ramón; Andrade-Campos, Marcio; Gibert Fernandez, Joan, 1988-; Sánchez González, Blanca; Fernández-Ibarrondo, Lierni; Fernández Rodríguez, M. Concepción; García Gisbert, Nieves, 1994-; Camacho Díaz, Laura; Lafuente, Marta; Vázquez, Ivonne; Colomo Saperas, Luis Alberto; Salar Silvestre, Antonio; Bellosillo Paricio, Beatriz (MDPI, 2024)
    Background: Cell-free DNA (cfDNA) analysis has become a promising tool for the diagnosis, prognosis, and monitoring of lymphoma cases. Until now, research in this area has mainly focused on aggressive lymphomas, with scanty ...
  • Cell-free DNA for genomic analysis in primary mediastinal large B-cell lymphoma
    Rivas-Delgado, Alfredo; Nadeu, Ferran; Andrade-Campos, Marcio; López, Cristina; Enjuanes¸ Anna; Mozas, Pablo; Frigola, Gerard; Colomo Saperas, Luis Alberto; Sánchez González, Blanca; Villamor, Neus; Beà, Sílvia; Campo, Elias; Salar Silvestre, Antonio; Giné, Eva; López Guillermo, Armando; Bellosillo Paricio, Beatriz (MDPI, 2022)
    High-throughput sequencing of cell-free DNA (cfDNA) has emerged as a promising noninvasive approach in lymphomas, being particularly useful when a biopsy specimen is not available for molecular analysis, as it frequently ...
  • Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea
    Alvarez-Larrán, Alberto; Díaz-González, Alvaro; Such, Esperanza; Mora, Elvira; Andrade-Campos, Marcio; García-Hernández, Carmen; Gómez-Casares, Maria-Teresa; García-Gutiérrez, Valentín; Carreño-Tarragona, Gonzalo; Garrote, Marta; Fernández-Ibarrondo, Lierni; Cervera, José; Bellosillo Paricio, Beatriz; Cervantes, Francisco; Hernández-Boluda, Juan Carlos; MPN Spanish Group (GEMFIN) (Nature Research, 2020)
  • Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease
    Andrade-Campos, Marcio; López de Frutos, Laura; Cebolla, Jorge J.; Serrano-Gonzalo, Irene; Medrano-Engay, Blanca; Roca-Espiau, Mercedes; Gómez-Barrera, Beatriz; Pérez-Heredia, Jorge; Iniguez, David; Giraldo, Pilar (BioMed Central, 2020)
    Background: Since enzyme replacement therapy for Gaucher disease (MIM#230800) has become available, both awareness of and the natural history of the disease have changed. However, there remain unmet needs such as the ...
  • Long-term follow-up of recovered MPN patients with COVID-19
    Barbui, Tiziano; Andrade-Campos, Marcio; Bellosillo Paricio, Beatriz; Rambaldi, Alessandro (Nature Research, 2021)
  • Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
    García Gisbert, Nieves, 1994-; Garcia-Ávila, Sara; Merchán, Brayan; Salido Galeote, Marta; Fernández Rodríguez, M. Concepción; Gibert Fernandez, Joan, 1988-; Fernández-Ibarrondo, Lierni; Camacho Díaz, Laura; Lafuente, Marta; Longarón Rozalen, Raquel; Espinet Solà, Blanca; Vélez, Patricia; Pujol Vallverdú, Ramon Maria; Andrade-Campos, Marcio; Arenillas Rocha, Leonor; Salar Silvestre, Antonio; Calvo Gonzalo, Xavier; Besses Raebel, Carles; Bellosillo Paricio, Beatriz (American Society of Hematology, 2022)
    Molecular and cytogenetic studies are essential for diagnosis and prognosis in patients with myelodysplastic syndromes (MDSs). Cell-free DNA (cfDNA) analysis has been reported to be a reliable noninvasive approach for ...
  • Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease
    Roca-Espiau, Mercedes; Andrade-Campos, Marcio; Cebolla, Jorge J.; López de Frutos, Laura; Medrano-Engay, Blanca; López-Royo, Maria-Pilar; Giraldo, Pilar (BioMed Central, 2019)
    Background: Chronic fatigue (CFg) is a prevalent symptom in Gaucher disease (GD) at diagnosis (79%) and remains in a quarter of patients after years of therapy. Bone abnormalities are present in over 70% and peripheral ...
  • Novel management and screening approaches for haematological complications of Gaucher's disease
    Giraldo, Pilar; Andrade-Campos, Marcio (Dove Press, 2021)
    Purpose: gaucher disease (GD) is the most common lysosomal storage disorder. The principal manifestations for its diagnosis and further monitoring include haematological manifestations such as anaemia, thrombocytopaenia, ...
  • Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features
    Calvo Gonzalo, Xavier; García Gisbert, Nieves, 1994-; Parraga, Ivonne; Gibert, Joan; Florensa Brichs, Lourdes; Andrade-Campos, Marcio; Merchan, Brayan; García-Avila, Sara; Montesdeoca, Sara; Fernández Rodríguez, M. Concepción; Salido Galeote, Marta; Puiggros Metje, Anna Maria; Espinet Solà, Blanca; Colomo Saperas, Luis Alberto; Roman-Bravo, David; Bellosillo Paricio, Beatriz; Ferrer Del Alamo, Ana; Arenillas Rocha, Leonor (American Society of Hematology, 2020)
    Oligomonocytic chronic myelomonocytic leukemia (OM-CMML) is defined as those myelodysplastic syndromes (MDSs) or myelodysplastic/myeloproliferative neoplasms, unclassifiable with relative monocytosis (≥10% monocytes) and ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking